释放Radix Astragali及其活性成分在胃治疗中的潜力
Pei-Pei Zhang1,2,3, Jing-Ni Tang4, Bo-Yu Xiang4
1School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha410208, China.
Journal of Asian natural products research
|March 20, 2025
概括
拉迪克斯阿斯特拉加利 (RA) 在治疗胃潰瘍 (GU) 方面表现有前途. 这份科学文献的综述表明,RA及其化合物是GU的潜在治疗选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 草药是一种草药.
背景情况:
- 胃 (GU) 是一种严重的胃肠道疾病.
- 传统的草药正在越来越多地探索其治疗潜力.
- 拉迪克斯阿斯特拉加利 (RA) 是中国传统医学的组成部分.
研究的目的:
- 系统地审查Radix Astragali (RA) 对胃潰瘍 (GU) 的保护作用.
- 确定RA中的关键化合物,其对抗GU的有效性已被证明.
- 评估目前对RA的证据,作为GU的新疗法.
主要方法:
- 在主要的科学数据库 (Web of Science,PubMed,Springer,ScienceDirect,CNKI,Wanfang) 中进行了全面的文献搜索.
- 纳入标准集中在研究RA,AS-IV,循环氨醇,黄糖多糖化物 (APS) 和黄 (AST) 用于GU治疗的研究上.
- 排除了关于癌前或癌后胃病变的研究.
主要成果:
- 经过审查的文献表明,Radix Astragali (RA) 具有对胃的保护作用.
- 特定的化合物,如AS-IV,环氨醇,APS和来自RA的AST,也显示了对GU的治疗益处.
- 有证据表明,RA在胃的治疗中起着有前途的作用.
结论:
- 拉迪克斯阿斯特拉加利 (RA) 和其成分具有作为胃的新型治疗剂的巨大潜力.
- 需要进一步研究 GU 的 RA 的机制和临床应用.
- 在开发新的 GU 治疗中,RA 是一个有前途的天然产品.
相关概念视频
01:26Peptic Ulcer Disease IV: Management
45
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
45
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
298
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
298
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
365
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
365
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
315
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
315
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
303
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
303
01:29Drugs for Treatment of Ulcerative Colitis in IBD
101
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
101